Timothy Schroeder - Jul 13, 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ Timothy Schroeder
Stock symbol
INMB
Transactions as of
Jul 13, 2021
Transactions value $
-$400,082
Form type
4
Date filed
7/14/2021, 04:07 PM
Previous filing
Jul 12, 2021
Next filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Sale -$400K -14.5K -13.57% $27.63 92.2K Jul 13, 2021 See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 22, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.00 to $29.00, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
F3 These shares of Common Stock are held by CTI Holdings, a company of which Mr. Schroeder is the majority shareholder. Mr. Schroeder has voting and investment control over these shares.